Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-01-01 @ 12:04 AM
Study NCT ID:
NCT04085367
Status:
COMPLETED
Last Update Posted:
2022-04-01
First Post:
2019-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-09
First Submit QC Date:
None
Study First Post Date:
2019-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-01
Results First Submit QC Date:
None
Results First Post Date:
2022-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-07
Last Update Post Date:
2022-04-01
Last Update Post Date Type:
ACTUAL